Bioorganic & Medicinal Chemistry · 2017 · 55 citations · 14 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryAntibacterial AgentsAntibacterial PharmacologyMetabolic Stability ScreeningMouse Liver MicrosomesMycobacterium Tuberculosis InfectionPhysicochemical PropertiesRat Liver MicrosomesStereochemical Structure - Activity RelationshipStructure - Activity Relationship OptimizationTuberculosis Drug Development
We identified a di-substituted triazolopyrimidine with anti-tubercular activity against Mycobacterium tuberculosis. Three segments of the scaffold were examined rationally to establish a structure-activity relationship with the goal of improving potency and maintaining good physicochemical properties. A number of compounds displayed sub-micromolar activity against Mycobacterium tuberculosis with no cytotoxicity against eukaryotic cells. Non-substituted aromatic rings at C5 and a two-carbon chain connecting a terminal aromatic at C7 were preferred features; the presence of NH at C7 and a lack of substituent at C2 were essential for potency. We identified compounds with acceptable metabolic stability in rodent and human liver microsomes. Our findings suggest that the easily-synthesized triazolopyrimidines are a promising class of potent anti-tubercular agents and warrant further investigation in our search for new drugs to fight tuberculosis.
14
Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against Tuberculosis
Lluís Ballell, Robert H. Bates, Rob J. Young et al. · ChemMedChem · 2013 · 310 citations · Full text
José M. Coterón, María Marco, Jorge Esquivias et al. · Journal of Medicinal Chemistry · 2011 · 284 citations · Full text
Ramesh Gujjar, Alka Marwaha, Farah El Mazouni et al. · Journal of Medicinal Chemistry · 2009 · 249 citations · Full text